Studies involving disease:NASH
| Study ID | Study Title | Species | Institute |
|---|---|---|---|
| ST002057 | Distinct Human Hepatocyte Lipidomics Profiles for Nonalcoholic Steatohepatitis and In Vitro-Induced Steatosis | Human | Monash Institute of Pharmaceutical Sciences |
| ST002097 | Functional metabolomics-based molecular profiling of acute and chronic hepatitis (Liver Metabolomics) | Mouse | Shanghai Center for Systems Biomedicine, Shanghai Jiaotong University |
| ST002098 | Functional metabolomics-based molecular profiling of acute and chronic hepatitis (Serum Metabolomics) | Mouse | Shanghai Center for Systems Biomedicine, Shanghai Jiaotong University |
| ST002099 | Functional metabolomics-based molecular profiling of acute and chronic hepatitis (Stool Metabolomics) | Mouse | Shanghai Center for Systems Biomedicine, Shanghai Jiaotong University |
| ST002100 | Functional metabolomics-based molecular profiling of acute and chronic hepatitis (Human Serum Metabolomics) | Human | Shanghai Center for Systems Biomedicine, Shanghai Jiaotong University |
| ST002101 | Functional metabolomics-based molecular profiling of acute and chronic hepatitis (Liver Lipidomics) | Mouse | Shanghai Center for Systems Biomedicine, Shanghai Jiaotong University |
| ST002866 | The role of PFAS exposures in nonalcoholic fatty liver disease and hepatocellular carcinoma in the Multiethnic Cohort | Human | University of Southern California |
